Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance-Reference-Cited by-同舟云学术

Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

Published:2013-03 Issue:3 Volume:63 Page:462-472
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Oddens Jorg,Brausi Maurizio,Sylvester Richard,Bono Aldo,van de Beek Cees,van Andel George,Gontero Paolo,Hoeltl Wolfgang,Turkeri Levent,Marreaud Sandrine,Collette Sandra,Oosterlinck Willem

Publisher

Elsevier BV

Subject

Urology

Reference18 articles.

1. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

2. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group;Brausi;J Urol,2011

3. EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder, the 2011 update;Babjuk;Eur Urol,2011

4. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

5. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non–muscle-invasive bladder cancer;Malmstrom;Eur Urol,2009

Cited by 399 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of smoking on the recurrence and progression of non-muscle-invasive bladder cancer;Clinical and Translational Oncology;2024-09-12

2. Efficacy and tolerance of hyperthermic intravesical chemotherapy (HIVEC) according to the number of instillations administered;World Journal of Urology;2024-09-11

3. Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer;BJU International;2024-08-25

4. Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer;Translational Oncology;2024-08

5. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08